Topical Wound Composition Combining Antimicrobials and Regeneration Agents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical treatments for chronic wounds are limited in effectively targeting multiple biochemical pathways, leading to prolonged healing times and increased healthcare costs, with existing technologies often focusing on single modes of action such as antimicrobials, debridement, or hydration.
Innovation Solution
A topical pharmaceutical composition combining antimicrobial compounds like silver sulfadiazine, bacitracin, neomycin, polymixin B, zinc oxide, vitamin E, and Coenzyme Q10, which targets microbial contamination and enhances the host's ability to regenerate tissue, providing multiple pharmacological responses to promote wound healing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If single mode of action treatments (antimicrobials, debridement, or hydration dressings) are used, then the treatment is simple and cost-effective, but the healing efficacy is limited and often leads to wound stasis without effectively treating the wound
Solution Approach 1:
The patent combines multiple pharmacologically active compounds with different modes of action into a single topical composition. The composition includes agents that target microbial biofilms, promote debridement, stimulate tissue regeneration, and provide hydration, thereby merging multiple treatment functions into one unified product that addresses multiple wound healing pathways simultaneously.
Solution Approach 2:
The topical composition is designed to perform multiple functions simultaneously: it acts as an antimicrobial agent against biofilms, a debridement promoter through collagenase activity, a tissue regeneration stimulator via growth factors, and a hydration provider through dressing components. This multi-functionality allows a single treatment to address various aspects of wound healing that previously required separate interventions.
2Productivity
If multiple biochemical pathways are targeted with combination treatments, then the healing efficacy is improved and healing time is reduced, but the treatment complexity and cost increase
Solution Approach 1:
The patent integrates multiple pharmacologically active compounds into a single topical composition that can be applied as one treatment. The composition includes compounds with distinct modes of action targeting different wound healing pathways, thereby achieving accelerated healing through multi-pathway intervention while simplifying the application process to a single product rather than multiple separate treatments.
3Object-affected harmful factors
If aggressive debridement is used to remove dead tissue, then the wound cleaning is effective, but the host tissue damage is increased and healing is delayed
Solution Approach 1:
The patent employs compounds that modulate the debridement process by changing its parameters from aggressive mechanical removal to controlled enzymatic action. The collagenase and other compounds facilitate selective degradation of necrotic tissue while preserving viable tissue through controlled biochemical reactions, thereby achieving effective debridement with minimal damage to host tissue and reduced risk of healing delays.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition demonstrates improved efficacy in treating acute and chronic wounds by inhibiting microbial growth, enhancing tissue regeneration, and reducing healing time, as evidenced by significant improvements in wound condition and reduced risk of complications like amputation.
Implementation Method 1
antimicrobial compounds, wherein the antimicrobial compounds include silver sulfadiazine, bacitracin, neomycin sulfate, and polymixin B sulphate
Implementation Method 2
incorporates a form of zinc and silver known to boost the antibacterial properties of individual antibiotics. Moreover, the present invention additionally incorporates a combination of one, or more trace elements, cofactors and vitamins, e.g., Zn, Vitamin E, CoQ10, to not only boost the mammalian host's immune response to fight infections
Implementation Method 3
promote tissue regeneration by helping to maintain mitochondrial integrity and increase the expression of the connective tissue growth factor (CTGF) responsible for extracellular tissue wound repair
Implementation Method 4
the agents are dispersed in a suitable carrier, such as a semi-soft or cream-like, gel- water-dispersible or water-soluble oil-in-water or water-in-oil emulsion carriers
Data Source
Figure 1
Figure 2
Figure 3
AI summary
In various embodiments, the present invention relates to a topical pharmaceutical composition for treating a skin condition, comprising a combination of agents, wherein the combination includes: a) one or more antimicrobial compounds; b) one or more trace elements; c) one or more tissue reconstruction elements; and d) one or more analgesics, and a pharmaceutically-acceptable carrier. In certain embodiments, the invention relates to a topical pharmaceutical composition comprising silver sulfadiazine, zinc oxide, lidocaine, bacitracin, neomycin (e.g., neomycin sulfate), polymixin B (e.g., polymixin B sulfate), vitamin E and Coenzyme Q10. In other embodiments, the invention relates to a method of treating a skin condition in a subject in need thereof, comprising administering to the subject a therapeutically-effective amount of topical pharmaceutical composition of the invention.